Adenosine-induced atrial proarrhythmia in children

Canadian Journal of Cardiology

Volumn 15, Issue 2, 1999, Pages 169-172

  Jaeggi, Edgar ^a,b   Chiu, Christine ^a   Hamilton, Robert ^a   Gilljam, Thomas ^a   Gow, Robert ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

Adenosine; Atrial fibrillation; Atrial flutter; Tachycardia; Wolff Parkinson White syndrome

Indexed keywords

ADENOSINE;

ADOLESCENT; ARTICLE; CASE REPORT; CHILDHOOD DISEASE; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HUMAN; MALE; NEWBORN; PATIENT MONITORING; SCHOOL CHILD; SUPRAVENTRICULAR TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

ADENOSINE; ADOLESCENT; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFANT, NEWBORN; MALE; TACHYCARDIA, SUPRAVENTRICULAR; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 0033066779     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. DiMarco JP, Sellers DT, Lerman BB, Greenberg ML, Berne RM, Bellardini J. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol 1985;6:417-24.
2. Rankin AC, Olkroyd KG, Chong E, Rae AP, Cobbe SM. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J 1989;62:195-203.
3. Till JA, Shineboume E, Rigby M, Clarke B, Ward DE, Rowland E. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J 1989;62:204-11.
4. McIntosh-Yellin NL, Drew BJ, Scheinman MM. Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia. J Am Coll Cardiol 1993;22:741-5.
5. Ralston MA, Knilans TK, Hannon DW, Daniels SR. Use of adenosine for diagnosis and treatment of tachyarrhythmias in pediatric patients. J Pediatr 1994;124:139-43.
6. Reed R, Falk JL, O'Brian J. Untoward reaction to adenosine therapy for supraventricular tachycardia. Am J Emerg Med 1991;9:566-70.
7. Crosson JE, Etheridge SP, Milstein S, Hesslein PS, Dunnigan A. Therapeutic and diagnostic utility of adenosine during tachycardia evaluation in children. Am J Cardiol 1994;74:155-60.
8. Smith JR, Goldberger JJ, Kadish AH. Adenosine induced polymorphic ventricular tachycardia in adults without structural heart disease. Pacing Clin Electrophysiol 1997;20:743-5.
9. Mulla N, Karpawich PP. Ventricular fibrillation following adenosine therapy for supraventricular tachycardia in a neonate with concealed Wolff-Parkinson-White syndrome treated with digoxin. Pediatr Emerg Care 1995;11:238-9.
10. Harrington GR, Froelich EG. Adenosine-induced torsades de pointes. Chest 1993;103:1299-301.
11. Strickberger SA, Man KC, Daoud EG, et al. Adenosine-induced atrial arrhythmia: a prospective analysis. Ann Intern Med 1997;127:417-22.
12. Munoz A, Leenhart A, Sassine A, Galley P, Puech P. Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia. Eur Heart J 1984;5:735-8.
13. Exner DV, Muzyka T, Gillis AM. Proarrhythmia in patients with the Wolff-Parkinson-White syndrome after standard doses of intravenous adenosine. Ann Intern Med 1995;122:351-2.
14. Brodsky MA, Hwang C, Hunter D, et al. Life-threatening alterations in heart rate after the use of adenosine in atrial flutter. Am Heart J 1995;130:564-71.
15. Rankin AC, Rae AP, Houston A. Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J 1993;69:263-5.
16. Lerman BB, Belasinelli L. Cardiac electrophysiology of adenosine. Basic clinical concepts. Circulation 1991;83:1499-509.
17. Visentin S, Wu S-N, Belardinelli L. Adenosine-induced changes in atrial action potential: contribution of Ca and K currents. Am J Physiol 1990;258:H1070-8.
18. Botteron GW, Smith JM. Spatial and temporal inhomogeneity of adenosine's effect on atrial refractoriness in humans: using atrial fibrillation to probe atrial refractoriness. J Cardiovasc Electrophysiol 1994;5:477-84.
19. Jaeggi E, Fouron JC, Drblik SP. Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 1998;132:335-9.
20. Pickoff AS, Singh S, Flinn CJ, McCormack J, Stolfi A, Gelband H. Atrial vulnerability in the immature canine heart. Am J Cardiol 1985;55:1402-6.
21. Rensma PL, Allessie MA, Lammers WJ, Bonke FI, Schalij H. The length of the excitation wave and susceptibility to reentrant atrial arrhythmias in normal concious dogs. Circ Res 1988;62:395-410.
22. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995;98:476-84.
23. Fujimura O, Klein GJ, Yee R, Sharma AD. The mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway? J Am Coll Cardiol 1990;15:1082-6.
24. Roark SF, McCarthy EA, Lee KL, Pritchett EL. Observations on the occurrence of atrial fibrillation in paroxysmal supraventricular tachycardia, Am J Cardiol 1986;57:571-5.
25. Josephson ME. Clinical Cardiac Electrophysiology. Philadelphia: Lea & Febiger, 1993:344.
26. Sharma AD, Klein GL, Guiraudon GM, Milstein S. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation 1985;72:161-9.
27. Honda T, Doi O, Hayasaki K, Honda T. Augmented sympathoadrenal activity during treadmill exercise in patients with Wolff-Parkinson-White syndrome and atrial fibrillation. Jpn Circ J 1996;60:43-9.
28. Michelucci A, Padeletti L. Monizzi D, et al. Atrial electrophysiologic properties of patients with asymptomatic Wolff-Parkinson-White syndrome. Eur Heart J 1988;9:479-83.
29. Garratt CJ, Griffith MJ, O'Nunain S, Ward DE, Camm J. Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections. Circulation 1991;84:1962-8.